Pharmsville Co., Ltd. (KOSDAQ:318010)
South Korea · Delayed Price · Currency is KRW 3,630.00
+10.00 (0.28%)
At close: Aug 24, 2026
Pharmsville Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 27,976 | 26,546 | 28,942 | 67,320 | 85,526 | 107,496 | |
Market Cap Growth | -27.53% | -8.28% | -57.01% | -21.29% | -20.44% | 25.69% |
Enterprise Value | -7,647 | -12,990 | -9,631 | 30,541 | 50,716 | 74,709 |
Last Close Price | 3620.00 | 3435.00 | 3531.31 | 7941.49 | 9891.64 | 12321.11 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.36 | 9.19 | 18.28 | 20.34 | 21.05 | 21.50 |
Forward PE | - | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 |
PS Ratio | 2.50 | 2.09 | 1.73 | 3.15 | 3.28 | 2.75 |
PB Ratio | 0.42 | 0.40 | 0.45 | 1.05 | 1.37 | 1.81 |
P/TBV Ratio | 0.42 | 0.40 | 0.45 | 1.06 | 1.38 | 1.83 |
P/FCF Ratio | 18.23 | 14.04 | - | 15.13 | 16.82 | 13.47 |
P/OCF Ratio | 18.20 | 14.02 | - | 14.47 | 16.44 | 12.99 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | - | 1.43 | 1.94 | 1.91 |
EV/EBITDA Ratio | - | - | - | 13.17 | 10.71 | 11.74 |
EV/EBIT Ratio | - | - | - | 18.59 | 12.48 | 12.15 |
EV/FCF Ratio | - | - | - | 6.86 | 9.98 | 9.36 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0 | 0 | 0.03 | 0.12 | 0.14 |
Debt / EBITDA Ratio | - | - | 0.06 | 0.94 | 1.54 | 1.26 |
Debt / FCF Ratio | 0.01 | 0.01 | - | 0.49 | 1.43 | 1.00 |
Net Debt / Equity Ratio | -0.54 | -0.59 | -0.58 | -0.58 | -0.57 | -0.57 |
Net Debt / EBITDA Ratio | 273.22 | 1119.32 | -92.96 | -16.11 | -7.51 | -5.30 |
Net Debt / FCF Ratio | -23.30 | -20.67 | 101.02 | -8.39 | -6.99 | -4.22 |
Asset Turnover | 0.17 | 0.19 | 0.24 | 0.29 | 0.35 | 0.55 |
Inventory Turnover | 2.77 | 2.74 | 2.65 | 3.16 | 2.99 | 2.85 |
Quick Ratio | 22.78 | 20.96 | 17.92 | 7.49 | 6.48 | 6.11 |
Current Ratio | 23.61 | 21.76 | 19.04 | 8.01 | 6.90 | 6.72 |
Return on Equity (ROE) | 4.57% | 4.42% | 2.46% | 5.22% | 6.66% | 8.68% |
Return on Assets (ROA) | -0.63% | -0.62% | -0.24% | 1.41% | 3.40% | 5.36% |
Return on Invested Capital (ROIC) | -1.71% | -2.01% | -0.87% | 5.10% | 12.06% | 18.63% |
Return on Capital Employed (ROCE) | -1.00% | -1.00% | -0.40% | 2.50% | 6.00% | 9.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 10.69% | 10.88% | 5.47% | 4.92% | 4.75% | 4.65% |
FCF Yield | 5.48% | 7.12% | -1.29% | 6.61% | 5.94% | 7.42% |
Dividend Yield | 5.43% | - | - | 1.26% | 1.01% | 0.81% |
Payout Ratio | 51.71% | 26.75% | 48.96% | 23.71% | 19.31% | 15.69% |
Buyback Yield / Dilution | -0.09% | -0.08% | 1.40% | 0.19% | - | 0.29% |
Total Shareholder Return | 5.34% | -0.08% | 1.40% | 1.45% | 1.01% | 1.11% |